The HeartMate 6 and CardioMEMS for Fixed Pulmonary Hypertension

Philipp Angleitner, Thomas Schlöglhofer, Dominik Wiedemann, Julia Riebandt, Andreas Strassl, Julia Mascherbauer, Matthias Kainz, Günther Laufer, Andreas Zuckermann, Daniel Zimpfer

Research output: Journal article (peer-reviewed)Journal article

2 Citations (Scopus)


Fixed pulmonary hypertension (FPH) is a contraindication for heart transplantation (HTX). However, this condition might be reversed by continuous left-ventricular unloading with a left-ventricular assist device. We present a case of apical hypertrophic cardiomyopathy with extensive left-ventricular endocardial calcification and severe FPH (systolic pulmonary artery pressure, 102 mm Hg). To bridge the patient to candidacy for HTX, two Abbott HeartMate 3 ventricular assist devices were implanted in a total artificial heart (TAH) configuration ("HeartMate 6"). Before TAH implantation, an Abbott CardioMEMS pressure sensor was implanted to assess reversal of FPH before listing for HTX.

Original languageEnglish
Pages (from-to)e80-e83
JournalASAIO Journal
Issue number5
Publication statusPublished - 01 May 2022


  • Heart Failure/complications
  • Heart Transplantation
  • Heart Ventricles
  • Heart, Artificial
  • Heart-Assist Devices
  • Humans
  • Hypertension, Pulmonary/surgery


Dive into the research topics of 'The HeartMate 6 and CardioMEMS for Fixed Pulmonary Hypertension'. Together they form a unique fingerprint.

Cite this